Cita APA

González Juanatey, C., Vázquez Rodríguez, T. R., Miranda Filloy, J. A., Gómez Acebo, I., Testa, A., García Porrúa, C., . . . González-Gay Mantecón, M. Á. (2012). Anti-TNF-alpha-adalimumab therapy is associated with persistent improvement of endothelial function without progression of carotid intima-media wall thickness in patients with rheumatoid arthritis refractory to conventional therapy.

Citación estilo Chicago

González Juanatey, Carlos, Tomás R. Vázquez Rodríguez, José Alberto Miranda Filloy, Inés|||0000-0001-8793-8314 Gómez Acebo, Ana Testa, Carlos García Porrúa, Amalia Sánchez Andrade, Javier Llorca Díaz, y Miguel Ángel|||0000-0002-7924-7406 González-Gay Mantecón. Anti-TNF-alpha-adalimumab Therapy Is Associated With Persistent Improvement of Endothelial Function Without Progression of Carotid Intima-media Wall Thickness in Patients With Rheumatoid Arthritis Refractory to Conventional Therapy. 2012.

Cita MLA

González Juanatey, Carlos, et al. Anti-TNF-alpha-adalimumab Therapy Is Associated With Persistent Improvement of Endothelial Function Without Progression of Carotid Intima-media Wall Thickness in Patients With Rheumatoid Arthritis Refractory to Conventional Therapy. 2012.